Group Intervention Study for Individuals with Dysarthria Following Stroke and Their Carers in Pakistan
NCT ID: NCT04427670
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2020-12-01
2024-07-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Auditory and Visual Cueing on Sensorimotor Recovery and Gait in Hemiplegia
NCT06059781
Using 5 Minute Videos for Numeracy and Literacy Challenged Stroke Survivors to Improve Outcomes
NCT02202330
Translation of Stroke Specific Quality of Life Questionnaire Into Local Languages of Pakistan
NCT04843254
Effect of Body Awarness Therapy on Balance and Coordination in Stroke
NCT05958732
Effect of Communication Partner Training Program for the Management of Persons With Aphasia
NCT05225922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Regular speech therapy
Regular speech therapy will be provided to the controlled group.
Regular speech therapy
Regular speech therapy will be provided to the controlled group.Regular speech therapy is one to one speech therapy session,conducted twice a week for the duration of eight weeks.This intervention is implemented to patients with dysarthria following stroke in a format of one patient and one therapist per session.
Group intervention
Group intervention will be provided to the experimental group.
Group intervention
Group intervention programme designed for stroke survivors with dysarthria and their carers. The programme was eight weeks long, with weekly two sessions, each session lasting for two hours, lead by speech language therapist and was comprised of activities which addressed participants education about their dysarthria and stroke. The role of family , peer and professional was to provide support and communication practice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group intervention
Group intervention programme designed for stroke survivors with dysarthria and their carers. The programme was eight weeks long, with weekly two sessions, each session lasting for two hours, lead by speech language therapist and was comprised of activities which addressed participants education about their dysarthria and stroke. The role of family , peer and professional was to provide support and communication practice.
Regular speech therapy
Regular speech therapy will be provided to the controlled group.Regular speech therapy is one to one speech therapy session,conducted twice a week for the duration of eight weeks.This intervention is implemented to patients with dysarthria following stroke in a format of one patient and one therapist per session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. History of dysarthria previous six monthes
3. Primary level of education
4. Functional hearing and visual ablities -
Exclusion Criteria
2. Patients with diagnosis severe psychological illness
3. Patient with developmental dysarthria
4. Patient who come alone without any attendent
40 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isra University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Saima maratab
principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saima M Ali, PhD
Role: PRINCIPAL_INVESTIGATOR
Isra University, Islamabad
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheikh Zayed medical Complex
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.